# A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

> **NCT06213363** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Beijing Tide Pharmaceutical Co., Ltd** · enrollment: 72 (estimated)

## Conditions studied

- Refractory Chronic Cough

## Interventions

- **DRUG:** TCR1672 tablet

## Key facts

- **NCT ID:** NCT06213363
- **Lead sponsor:** Beijing Tide Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2024-10
- **Final completion:** 2024-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213363, "A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT06213363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*